Tariffs
Commentary
Tariffs Won’t Secure Our Drug Supply Chain—They’ll Break It
The Trump administration is considering massive “Section 232” tariffs on imported medicines from key U.S. allies, including the European Union, the United Kingdom, Switzerland, Japan, and South Korea. While tariffs on some countries, such as EU member states, could be capped at 15%, other tariffs could reportedly be set as ...
Commentary
The New Medicine Tariffs Are a Prescription for Disaster
President Trump has recently struck trade agreements with the European Union and Japan. Both deals will impose a 15 percent tariff on imported prescription drugs and active pharmaceutical ingredients. White House officials believe these tariffs will benefit Americans by nudging pharmaceutical companies to relocate their manufacturing operations stateside in order ...
Business & Economics
Tariffs Either Can’t, Won’t, Or Shouldn’t Re-shore Manufacturing Jobs
Despite the unanimous ruling from the Court of International Trade, the Supreme Court will likely decide whether the International Emergency Economic Powers Act empowers President Trump to levy global tariffs. As this process will take time to play out, economic uncertainty will persist for the foreseeable future. What isn’t uncertain ...
Commentary
Potential Tariffs Will Harm Patients In The Name Of Protecting Them
Two months ago, the Commerce Department launched an investigation into whether pharmaceutical imports pose a threat to national security (i.e., a Section 232 investigation). Not only are the investigation’s accusations groundless, implementing the proposed remedy – more tariffs – will create the very problems that the investigation hopes to avoid. ...
Drug Importation
Pipes: “Imposing tariffs on pharmaceutical products and ingredients would be a grave mistake”
Click here to download a copy of Pipes’ comments Thank you for inviting public input on the Department’s Section 232 examination of pharmaceutical imports and their relevance to U.S. national security interests. As president and CEO of the Pacific Research Institute and a longtime healthcare policy analyst, I’ve spent over ...
Blog
Why Your Next Bottle of French Champagne Could Cost More: Tariffs & US Sparkling Wine Options
When I read the news that prices on French Champagne could soon be soaring under President Trump’s tariff plan, my first response was to quickly get to my nearest Costco. Veuve Clicquot champagne, still made much like it was when first developed over 200 years ago by the “Grande Dame” ...
Commentary
Pharmaceutical Tariffs Will Have Horrific Side Effects
President Trump implemented a raft of tariffs this week. All imports are subject to a 10% import duty. Those from China are subject to a 145% tariff. Pharmaceuticals appear to be exempt from the tariffs — for now. Drug manufacturers expect to get hit with tariffs at some point; they’re ...
Business & Economics
An economist explains what trade deficits really mean
Believing the myth that trade deficits are bad, the Trump Administration imposed global reciprocal tariffs this week. The proposal threatens to derail economic prosperity and trigger a barn burner of a recession. The fallacy of this myth can be clearly seen in the U.S. economic data. Over the last half-century ...
Business & Economics
Tom Campbell – On Tariffs, DOGE and Cutting Government Waste
This week, we’re joined by former Congressman, state legislator, state Director of Finance and constitutional law scholar Tom Campbell – rated as the top government waste fighter during his tenure in the House. We discuss the President’s tariff proposals and the DOGE effort, whether Elon Musk’s team is following the ...
Business & Economics
Trade Wars Hurt Farmers
Before promising to impose tariffs on our nearest trade partners — Mexico and Canada — President Donald Trump told American farmers that they should get ready to sell more of their products domestically. The trouble with that optimism is that most farms are not corporate giants, but family operations that ...
Tariffs Won’t Secure Our Drug Supply Chain—They’ll Break It
The Trump administration is considering massive “Section 232” tariffs on imported medicines from key U.S. allies, including the European Union, the United Kingdom, Switzerland, Japan, and South Korea. While tariffs on some countries, such as EU member states, could be capped at 15%, other tariffs could reportedly be set as ...
The New Medicine Tariffs Are a Prescription for Disaster
President Trump has recently struck trade agreements with the European Union and Japan. Both deals will impose a 15 percent tariff on imported prescription drugs and active pharmaceutical ingredients. White House officials believe these tariffs will benefit Americans by nudging pharmaceutical companies to relocate their manufacturing operations stateside in order ...
Tariffs Either Can’t, Won’t, Or Shouldn’t Re-shore Manufacturing Jobs
Despite the unanimous ruling from the Court of International Trade, the Supreme Court will likely decide whether the International Emergency Economic Powers Act empowers President Trump to levy global tariffs. As this process will take time to play out, economic uncertainty will persist for the foreseeable future. What isn’t uncertain ...
Potential Tariffs Will Harm Patients In The Name Of Protecting Them
Two months ago, the Commerce Department launched an investigation into whether pharmaceutical imports pose a threat to national security (i.e., a Section 232 investigation). Not only are the investigation’s accusations groundless, implementing the proposed remedy – more tariffs – will create the very problems that the investigation hopes to avoid. ...
Pipes: “Imposing tariffs on pharmaceutical products and ingredients would be a grave mistake”
Click here to download a copy of Pipes’ comments Thank you for inviting public input on the Department’s Section 232 examination of pharmaceutical imports and their relevance to U.S. national security interests. As president and CEO of the Pacific Research Institute and a longtime healthcare policy analyst, I’ve spent over ...
Why Your Next Bottle of French Champagne Could Cost More: Tariffs & US Sparkling Wine Options
When I read the news that prices on French Champagne could soon be soaring under President Trump’s tariff plan, my first response was to quickly get to my nearest Costco. Veuve Clicquot champagne, still made much like it was when first developed over 200 years ago by the “Grande Dame” ...
Pharmaceutical Tariffs Will Have Horrific Side Effects
President Trump implemented a raft of tariffs this week. All imports are subject to a 10% import duty. Those from China are subject to a 145% tariff. Pharmaceuticals appear to be exempt from the tariffs — for now. Drug manufacturers expect to get hit with tariffs at some point; they’re ...
An economist explains what trade deficits really mean
Believing the myth that trade deficits are bad, the Trump Administration imposed global reciprocal tariffs this week. The proposal threatens to derail economic prosperity and trigger a barn burner of a recession. The fallacy of this myth can be clearly seen in the U.S. economic data. Over the last half-century ...
Tom Campbell – On Tariffs, DOGE and Cutting Government Waste
This week, we’re joined by former Congressman, state legislator, state Director of Finance and constitutional law scholar Tom Campbell – rated as the top government waste fighter during his tenure in the House. We discuss the President’s tariff proposals and the DOGE effort, whether Elon Musk’s team is following the ...
Trade Wars Hurt Farmers
Before promising to impose tariffs on our nearest trade partners — Mexico and Canada — President Donald Trump told American farmers that they should get ready to sell more of their products domestically. The trouble with that optimism is that most farms are not corporate giants, but family operations that ...
